Tweet by Michael “Mike” Glp1 impact behavior

Michael “Mike” Albert, MD ⁦‪@MichaelAlbertMD‬⁩ Bc most of the GLP1 skeptics don’t read the science & have never talked to a pt, let me break it down. Behavior is the manifestation of lots of complex neurobio. GLP1s dampen/shut off certain signals, thus making the pursuit of certain health behaviors easier & more accessible. pic.twitter.com/jHRBA75GWv 9/16/22,Continue reading “Tweet by Michael “Mike” Glp1 impact behavior”

Tweet by CRISPR RX

Fyodor Urnov ⁦‪@UrnovFyodor‬⁩ CRISPR has delivered on a key aspect of its promise as a platform technology: going from disease 1 to disease 2 requires changing only 20 nt in an RNA. This is exactly what ⁦‪@intelliatx‬⁩ just did: the HAE data look as good as the TTR ones. YAY+BRAVO! statnews.com/2022/09/16/int… 9/16/22, 8:13 AM JosephContinue reading “Tweet by CRISPR RX”

Tweet by Neuroscience News loperamide for autism.

Neuroscience News ⁦‪@NeuroscienceNew‬⁩ Loperamide, a common anti-diarrhea medication, could help treat core symptoms associated with autism spectrum disorder. The drug activates the μ-opioid receptor, helping to improve social behaviors. #asd #neuroscience #science neurosciencenews.com/anti-diarrhea-… 9/12/22, 3:38 AM Joseph Thornton